Skip to content

Alto Neuroscience, Inc.

ANRO

CIK 0001999480

← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$73.29M
−2.9% YoY Q1 May 2026
EPS Diluted (TTM)
−$2.53
+12.4% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$62.98M
Q1 May 2026
Cash
$263.76M
Q1 May 2026
Total Debt
$16.02M
Q1 May 2026
Shares Outstanding
35.09M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings